Dr Rupert McShane
Chair, ECT and Related Treatments Committee
Dr Rupert McShane’s interest is in treatment resistant depression and dementia. He leads the Oxfordshire ECT and ketamine services and runs a memory clinic.
His main focus is developing policy and monitoring arrangements for rapidly acting antidepressants such as ketamine.
Dr McShane led the international academic conference on Ketamine and Related Compounds for Psychiatric Disorders in March 2018. He works on ways of optimizing the effects of ketamine and is local PI for trials of rapidly acting antidepressants.
Dr McShane led a qualitative study of ECT, which led to the creation of a Healthtalk module of patients talking about their experience. As Co-ordinating Editor of the Cochrane Dementia and Cognitive Improvement Group, he has led programmes on reviews of diagnostic test accuracy and modifiable risk factors for dementia.
He supports NIHR funded and commercial dementia trials as local PI.